Li-Fraumeni syndrome

2,028views

Li-Fraumeni syndrome

Dr. Andrews

Dr. Andrews

Cell cycle
Oncogenes and tumor suppressor genes
Non-Hodgkin lymphoma
Hodgkin lymphoma
DiGeorge syndrome
Hydronephrosis
Acute pyelonephritis
Chronic pyelonephritis
Vesicoureteral reflux
Bladder exstrophy
BK virus (Hemorrhagic cystitis)
Non-urothelial bladder cancers
Development of the umbilical cord
Development of the fetal membranes
Dizziness and vertigo: Clinical
Reactive arthritis
Klinefelter syndrome
Testicular tumors: Pathology review
DNA alkylating medications
Androgens and antiandrogens
PDE5 inhibitors
Adrenergic antagonists: Alpha blockers
Estrogens and antiestrogens
Progestins and antiprogestins
Aromatase inhibitors
Uterine stimulants and relaxants
Anatomy of the pelvic cavity
Pelvic inflammatory disease
Vulvar cancer: Clinical
Vaginal and vulvar disorders: Pathology review
Chlamydia trachomatis
Papulosquamous skin disorders: Clinical
Transitional cell carcinoma
Human papillomavirus
Paget disease of the breast
Vascular tumors
Development of the digestive system and body cavities
Nephroblastoma (Wilms tumor)
Development of the renal system
Antimetabolites for cancer treatment
Hypothyroidism: Pathology review
Hashimoto thyroiditis
Hyperthyroidism: Pathology review
Thyroid cancer
Thyroid nodules and thyroid cancer: Pathology review
Riedel thyroiditis
Waterhouse-Friderichsen syndrome
Hyperaldosteronism
Adrenal masses and tumors: Clinical
Sheehan syndrome
Cervical cancer
Ovarian cyst
Pheochromocytoma
Multiple endocrine neoplasia: Pathology review
Carcinoid syndrome
Vaginal cancer: Clinical
Acromegaly
Multiple endocrine neoplasia
Parathyroid hormone
Cystic fibrosis
Preeclampsia & eclampsia
Necrotizing enterocolitis
Neonatal respiratory distress syndrome
Galactosemia
Phenylketonuria (NORD)
WAGR syndrome
Focal segmental glomerulosclerosis (NORD)
Nephrotic syndromes: Pathology review
Membranoproliferative glomerulonephritis
Nephritic syndromes: Pathology review
IgA nephropathy (NORD)
Diabetic nephropathy
Membranous nephropathy
Minimal change disease
Ribonucleotide reductase inhibitors
Alport syndrome
Rapidly progressive glomerulonephritis
Goodpasture syndrome
Neurogenic bladder
Polycystic ovary syndrome
Endometrial hyperplasia
Renal system anatomy and physiology
Medullary cystic kidney disease
Krukenberg tumor
Polycystic kidney disease
Multicystic dysplastic kidney
Medullary sponge kidney
Horseshoe kidney
The role of the kidney in acid-base balance
Pancreatic cancer
Pancreatic neuroendocrine neoplasms
Acute pancreatitis
Chronic pancreatitis
Microtubule inhibitors
Bordetella pertussis (Whooping cough)
Topoisomerase inhibitors
Breast cancer
Prostate disorders and cancer: Pathology review
Antidiuretic hormone
Estrogen and progesterone
Li-Fraumeni syndrome
Renal agenesis
Gene regulation
Familial adenomatous polyposis
Mendelian genetics and punnett squares
Uterine fibroid
Respiratory acidosis
Legionella pneumophila (Legionnaires disease and Pontiac fever)
Antituberculosis medications
Cell wall synthesis inhibitors: Cephalosporins
Cell wall synthesis inhibitors: Penicillins
Peutz-Jeghers syndrome
Anatomy of the perineum

Flashcards

Li-Fraumeni syndrome

0 of 8 complete

Key Takeaways

Li-Fraumeni syndrome (LFS) is a rare inherited genetic disorder. People with Li-Fraumeni syndrome have an increased risk of developing multiple malignancies, typically sarcoma, breast carcinoma, leukemia, and adrenocortical carcinoma cancer.

In this condition, cancers often develop cancer at a young age and people are also more likely to have multiple tumors than people without this syndrome. The cause of Li-Fraumeni syndrome is a mutation in the p53 tumor suppressor gene. This gene provides instructions for making a protein that regulates the cell cycle and prevents genomic mutations that might lead to these cancers.